Patent · US Active

Compositions and methods for inhibiting expression of an RNA from West Nile virus

US8592570B2 · kind B2 · utility

0Cited by

2References

19Claims

0Family size

Assignee

Alnylam Pharmaceuticals, Inc. · US

Inventors

Dinah Wen-Yee Sah · Boston, US
Qingmin Chen · Wuxi, CN

Key dates

Filing date	Oct 6, 2009
Grant date	Nov 26, 2013
Priority date	—
Expiry date	Oct 6, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2310/14
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

This invention relates to double-stranded ribonucleic acid (dsRNA), and its use in mediating RNA interference to inhibit the expression of an RNA from the West Nile virus (WNV), and the use of the dsRNA to treat pathological processes mediated by WNV infection, such as viral encephalitis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.